March 2024
07 Aug 2024
The global continuous renal replacement therapy market was evaluated at USD 1.46 billion in 2023 and is anticipated to be worth around USD 3.24 billion by 2033, growing at a CAGR of 8.3% during the forecast period. The growing number of medical applications is expected to drive the growth of the market.
The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/3613
The continuous renal replacement therapy market deals with common treatment for critically sick patients with acute kidney injury, particularly hemodynamically unstable patients. A temporary reduction in kidney function that results in the accumulation of urea, creatinine, and other waste products is called acute kidney injury. It has been connected to water and sodium retention and the development of metabolic disturbances such as hyperkalemia and metabolic acidosis. The continuous renal replacement therapy market is driven by the increasing prevalence of chronic kidney diseases. In addition, the growing clinical advantage of CRRT over intermittent blood purification, rising incidences of sepsis, growing number of ICU patients with AKI, and rising prevalence of AKI globally are further anticipated to drive the growth of the market during the forecast period.
The growing number of medical applications fuels the market growth
The increasing growth in the number of medical applications is enhancing the market for continuous renal replacement therapy. Candidates for CRRT are patients with acute renal failure who also have potential comorbidities, such as various organ defects or failure in their circulatory and cardiac systems, such as edema and cardiac insufficiency. Continuous renal replacement therapy can be used to treat different organ failures, postoperative liver failure, fulminant hepatitis, and acute pancreatitis, in addition to renal failure. Additionally, the increasing prevalence of chronic kidney diseases such as inflammatory kidney disease, cardiovascular disease, hypertension, and diabetes further drives the growth of the continuous renal replacement therapy market during the forecast period.
However, the growing number of complications connected with CRRT may restrain the market growth
The increasing number of complications related to continuous renal replacement therapy creates a significant challenge to market growth. The introduction of a large-bore central venous catheter, which may require to be held in a place for a longer period of time, is needed to begin continuous renal replacement therapy. In addition, the lack of skilled professionals in emerging countries will create a significant challenge. A lack of awareness about CRRT and an unfavorable reimbursement scenario may create significant challenges. Thus, these factors are expected to restrain the growth of the continuous renal replacement therapy market.
Recent Innovation in Continuous Renal Replacement Therapy by Fresenius Medical Care
Recent Innovation in Continuous Renal Replacement Therapy by Thermo Fisher Scientific
Asia Pacific is expected to grow fastest during the forecast period. The region has the largest market share due to factors such as increasing awareness of advanced renal care, the growing geriatric population, and the increasing prevalence of kidney diseases. In addition, strategic initiatives by major market players, increasing adoption of innovative CRRT technologies, rising healthcare expenditure, and growing healthcare infrastructure are further anticipated to drive the growth of the continuous renal replacement therapy market in the region.
China, India, Japan, and South Korea are the leading countries in the Asia Pacific. China is the fastest-growing country in the CRRT. Continuous renal replacement therapy is broadly utilized for treating clinically sick patients in the Chinese emergency department. A panel of international experts and domestic emergency medicine of CRRT will discuss RCA-related problems, such as the pros and cons of RCA in CRRT anticoagulation, monitoring of RCA, and the principle of RCA. China is associated with severe morbidity and mortality. Thus, these factors are expected to enhance the growth of the market in the Asia Pacific region.
North America dominated the continuous renal replacement market in 2023.
The increasing substantial investments in advanced medical technologies, growing well-established healthcare infrastructure, and increasing high prevalence of renal diseases are expected to drive the growth of the market in the region. The region benefits from a robust research and development environment driving technological innovations in continuous renal replacement therapy. In addition, increasing awareness among healthcare professionals and a proactive regulatory framework are further anticipated to enhance the market growth. The U.S. and Canada are the major well-developed countries in the region and further contributed to propelling the continuous renal replacement therapy market in North America.
Rising demand for CRRT in developing regions
The growing large number of people in developing regions and the increasing geriatric population globally further create significant opportunities. India and China have the largest population in the world. The over-aged population is more affected by renal diseases. This is due to comorbid conditions such as chronic heart failure, diabetes mellitus, and arterial hypertension, which may cause renal damage. Most of the older population will be living in middle and low-income economies. In addition, the population's unhealthy lifestyle and rapid urbanization in countries in various emerging regions. Thus, these factors are expected to enhance the growth of the continuous renal replacement therapy market in the coming years.
| Report Attribute | Key Statistics |
| Market Revenue in 2024 | USD 1.58 Billion |
| Market Revenue by 2033 | USD 3.24 Billion |
| CAGR | 8.3% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2023 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Market Segmentation
By Product
By Modality
Buy this Research Report@ https://www.precedenceresearch.com/checkout/3613
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
March 2024
March 2024
July 2024
February 2024